Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032
Overview
The Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is expected to reach a 608.86 USD Million by 2032 and is projected to grow at a CAGR of 15.32% from 2025 to 2032.
Revenue, 2024 (USD Million)
247.12
Forecast, 2032 (USD Million)
608.86
CAGR, 2024 - 2032
15.32%
Report Coverage
Asia-Pacific
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market 2018-2032 USD Million
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 247.12 USD Million
- Projected Market Size (2032): 608.86 USD Million
- CAGR (2025-2032): 15.32%
Key Findings of Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market
- The Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market was valued at 247.12 USD Million in 2024.
- The Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is likely to grow at a CAGR of 15.32% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Human iPSCs in Type Segment accounted for the largest share of the market with a revenue of 173.62 USD Million
- The fastest growing segment Biotechnology & Pharmaceutical Companies in End User Segment grew Fastest with a CAGR of 18.00% during the forecast period from 2024 to 2032.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Scope
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope
Product
- Instruments
- Services
- Consumables & Kits
Application
- Others
- 3D Bioprinting
- Stem Cell Banking
- Toxicology Screening
- Regenerative Medicine
- Cellular Therapy
- Disease Modelling
- Academic Research
- Drug Discovery And Development
Type
- Mouse iPSCs
- Human iPSCs
Cell Source
- Blood Cells
- Skin Cells
End User
- Others
- Diagnostic Laboratories
- Research Laboratories
- Biotechnology & Pharmaceutical Companies
Distribution Channel
- Retail Sales
- Direct Tender
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 247.12 USD Million |
| Market Value in 2032 | 608.86 USD Million |
| CAGR (2025-2032) | 15.32% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Application,Type,Cell Source,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 247.12 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 100.91 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Product
- Consumables & Kits is the largest segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 128.22 USD Million in the year 2024.
- Consumables & Kits is the Fastest growing segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 16.50 % in forecast period 2025-2032.
-
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Application
- Drug Discovery And Development is the largest segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 56.55 USD Million in the year 2024.
- Academic Research is the Fastest growing segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 16.14 % in forecast period 2025-2032.
-
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Type
- Human iPSCs is the largest segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 173.62 USD Million in the year 2024.
- Human iPSCs is the Fastest growing segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 16.22 % in forecast period 2025-2032.
-
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Cell Source
- Skin Cells is the largest segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 160.68 USD Million in the year 2024.
- Skin Cells is the Fastest growing segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 15.55 % in forecast period 2025-2032.
-
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By End User
- Biotechnology & Pharmaceutical Companies is the largest segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 122.99 USD Million in the year 2024.
- Biotechnology & Pharmaceutical Companies is the Fastest growing segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 18.00 % in forecast period 2025-2032.
-
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a revenue of 163.66 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market to 2032 with a Growth rate of 16.50 % in forecast period 2025-2032.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Lonza | |||
| Thermo Fisher Scientific Inc. | |||
| Evotec SE | |||
| FUJIFILM Corporation | |||
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Product,Application,Type,Cell Source,End User,Distribution Channel.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 247.12(Revenue in USD Million) in 2022.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 15.32% during the forecast period of 2024 to 2032.
The Human iPSCs segment is expected to dominate the Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market, holding a largest market share of 173.62 USD Million in 2024
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Scope
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Segmentation & Scope
Product
- Instruments
- Services
- Consumables & Kits
Application
- Others
- 3D Bioprinting
- Stem Cell Banking
- Toxicology Screening
- Regenerative Medicine
- Cellular Therapy
- Disease Modelling
- Academic Research
- Drug Discovery And Development
Type
- Mouse iPSCs
- Human iPSCs
Cell Source
- Blood Cells
- Skin Cells
End User
- Others
- Diagnostic Laboratories
- Research Laboratories
- Biotechnology & Pharmaceutical Companies
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Product,Application,Type,Cell Source,End User,Distribution Channel.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 247.12(Revenue in USD Million) in 2022.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 15.32% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market for final year is USD 608.86 (USD Million).
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is segmented based on Segmentation Product,Application,Type,Cell Source,End User,Distribution Channel.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market was valued at USD 247.12(Revenue in USD Million) in 2022.
Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market is projected to grow at a CAGR of 15.32% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market for final year is USD 608.86 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.